PRNewswire Boston [US]/Bangalore (Karnataka) [India], August 11: Zumutor Biologics Inc “Zumutor”, a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today announces that the US Food and Drug Administration (FDA) has granted the company’s Investigational New Drug (IND) application for the novel drug ZM008 to…Read More
Zumutor Biologics Inc announces FDA clearance of IND application of ZM008 a novel monoclonal antibody drug against multiple solid cancers
